Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludesBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f100 (Published 09 January 2013) Cite this as: BMJ 2013;346:f100
- Zosia Kmietowicz
Women with menorrhagia reported more improvement in bleeding and quality of life with the levonorgestrel releasing intrauterine system than with other treatments available in primary care, a two year study in England has found.1
Women fitted with the levonorgestrel releasing intrauterine system (also known as LNG-IUS or Mirena) were also more likely to stick with treatment, found the study, called the Effectiveness and Cost-Effectiveness of Levonorgestrel-Containing Intrauterine System in Primary Care against Standard Treatment for Menorrhagia (ECLIPSE) study.
Researchers from the Universities of Birmingham and Nottingham randomised 571 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial